Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)

Kimberly D Leuthner,1 Kristin A Buechler,1 David Kogan,1 Agafe Saguros,1 H Stephen Lee2 1Department of Pharmaceutical Services, University Medical Center of Southern Nevada, Las Vegas, NV, USA; 2Roseman University of Health Sciences College of Pharmacy, Henderson, NV, USA Abstract: Acute bacterial...

Cijeli opis

Bibliografski detalji

Glavni autori:	Leuthner KD, Buechler KA, Kogan D, Saguros A, Lee HS
Format:	Artigo
Jezik:	Inglês
Izdano:	Dove Medical Press 2016-06-01
Serija:	Therapeutics and Clinical Risk Management
Teme:	dalbavancin lipoglycopeptide ABSSSI skin and skin structure infection dosing schedule Gram-positive resistance
Online pristup:	https://www.dovepress.com/clinical-efficacy-of-dalbavancin-for-the-treatment-of-acute-bacterial--peer-reviewed-article-TCRM
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!